Status:
COMPLETED
Symptom Management for YA Cancer Survivors
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Young Adult
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
Symptom interference is common for survivors of young adult cancer (aged 18-39 at diagnosis) and impacts their abilities to achieve normative life goals (e.g., education, careers, independence, romant...
Detailed Description
More than 60,000 young adults (YAs) aged 18-39 are diagnosed with cancer in the US each year. Advances in treatment have yielded five year survival rates \>70% suggesting that the majority of YAs will...
Eligibility Criteria
Inclusion
- Young Adult Cancer Survivors Participating in Intervention Development Interviews
- Eligibility Criteria
- Diagnosed with hematologic, breast, gastrointestinal, or endocrine cancers, melanoma, or germ cell tumors
- Diagnosed with cancer as a young adult
- Under the care of a medical provider at the Duke Cancer Institute
- Completed curative treatment involving multimodal therapy within the last five years
- Able to speak and read English
- Able to give informed consent
- Exclusion Criteria
- Nonambulatory
- Major mental illness, i.e., schizophrenia
- Untreated or uncontrolled mental illness, i.e., bipolar
- Residence greater than 100 miles from the research site
- Medical Providers Participating in Intervention Development Interviews Eligibility criteria
- o Provide care to young adult cancer survivors at the Duke Cancer Institute
- Young Adult Cancer Survivor User Testers
- Eligibility Criteria
- Diagnosed with hematologic, breast, gastrointestinal cancers, or endocrine cancers, melanoma, or germ cell tumors
- Diagnosed with cancer as a young adult
- Under the care of a medical provider at the Duke Cancer Institute
- Completed curative treatment involving multimodal therapy within the last five years
- Able to speak and read English
- Able to give informed consent
- Exclusion Criteria
- Nonambulatory
- Major mental illness, i.e., schizophrenia
- Untreated or uncontrolled mental illness, i.e., bipolar
- Residence great than 100 miles from the research site
- RCT Participants
- Eligibility Criteria:
- diagnosed with cancer as a YA (aged 18-39)
- diagnosis of hematologic, breast, endocrine or gastrointestinal cancer, melanoma, or germ cell tumor
- receiving care at the Duke Cancer Institute
- completed curative treatment involving multimodal therapy within the last 2 years
- able to speak/read English; and able to give informed consent.
- Exclusion Criteria:
- non-ambulatory
- major mental illness (i.e., schizophrenia)
- untreated or uncontrolled mental illness (i.e., bipolar disorder)
Exclusion
Key Trial Info
Start Date :
January 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2024
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04035447
Start Date
January 22 2020
End Date
June 15 2024
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Institute
Durham, North Carolina, United States, 27710